# RESNIBEN
> **NDA220258** · New Drug Application · Sponsor: AZURITY · Approved 2025-10-24
## Drug
- **FDA Application Number:** NDA220258
- **Application type:** New Drug Application
- **Brand name:** RESNIBEN
- **Generic name:** Cabozantinib
- **Active ingredients:** CABOZANTINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AZURITY
- **First approval:** 2025-10-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220258)
---
*AI Analytics · CC0 1.0*